Close



Mar 22, 2024 07:00AM
Jan 31, 2024 09:44AM
Dec 6, 2023 07:01AM
Dec 6, 2023 07:00AM
Jul 12, 2023 10:25AM
May 5, 2023 07:18AM
Apr 21, 2023 07:15AM Dr. Reddys Labs (RDY) Launches Treprostinil Injection in the U.S.
Apr 5, 2023 06:55AM
Jan 27, 2023 07:03AM
Jul 27, 2022 03:26AM
Jul 22, 2022 06:17AM
Jul 8, 2022 11:51AM
Jul 8, 2022 11:48AM
Jun 24, 2022 07:31AM Eton Pharmaceuticals (ETON) Announces Sale of Hospital Products to Dr. Reddy’s (RDY) for Up to $50M
Jun 24, 2022 07:30AM
Jun 24, 2022 07:30AM
Jun 14, 2022 02:51AM
May 27, 2022 10:15AM
May 24, 2022 01:41PM
May 24, 2022 01:40PM
Apr 20, 2022 12:41PM Dr. Reddy's Laboratories Announces the Launch of Posaconazole Delayed-Release Tablets in the U.S. Market
Apr 5, 2022 06:52AM
Feb 9, 2022 09:19AM
Feb 9, 2022 09:17AM
Dec 10, 2021 01:46PM
Dec 9, 2021 11:47PM
Dec 9, 2021 03:18AM
Dec 9, 2021 12:50AM Prestige BioPharma and Dr. Reddy’s announce partnership to commercialize trastuzumab biosimilar in select countries in Latin America and Southeast Asia
Dec 8, 2021 09:00PM
Oct 29, 2021 08:59AM
Oct 29, 2021 08:59AM
Oct 19, 2021 05:30AM
Oct 19, 2021 12:14AM
Oct 15, 2021 01:40PM
Oct 14, 2021 08:00AM Exelixis In-Licenses Second Anti-Cancer Compound from Aurigene Following FDA Acceptance of Investigational New Drug Application for Phase 1 Clinical Trial in Non-Hodgkin’s Lymphoma
Sep 9, 2021 08:30AM
Sep 7, 2021 07:34AM
Sep 7, 2021 07:30AM
Aug 31, 2021 05:34AM
Aug 31, 2021 02:43AM
Aug 18, 2021 08:30AM
Aug 4, 2021 10:43AM Dr. Reddys Labs (RDY) Sells its U.S. and Canada Territory Rights for ELYXYB to BioDelivery Sciences
Aug 4, 2021 10:32AM
Aug 3, 2021 08:32AM
Jun 22, 2021 02:07AM
May 13, 2021 03:21AM
May 12, 2021 12:56AM
Apr 29, 2021 10:41AM
Apr 7, 2021 04:56AM Dr. Reddy's Laboratories Announces the Launch of a Generic Version of Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg in the U.S. Market
Feb 22, 2021 01:13AM

251,370 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All